Join to View Full Profile
1364 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-7777
Dr. Ravindranathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Deepak Ravindranathan, MD, is a healthcare professional based in Atlanta, GA, specializing in Internal Medicine with subspecialties in Hematology and Oncology. He completed a fellowship in Hematology and Medical Oncology at Emory University School of Medicine from 2019 to 2022 and an internship in Internal Medicine from 2016 to 2019 at the same institution. He graduated from the University of North Carolina at Chapel Hill School of Medicine in 2016. Dr. Ravindranathan has several publications, including studies on cancer treatments and racial disparities in COVID-19 outcomes among cancer patients, published in reputable journals like The Oncologist and JAMA Network Open. His research has been cited multiple times by other publications.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2019 - 2022- Emory University School of MedicineInternship, Internal Medicine, 2016 - 2019
University of North Carolina at Chapel Hill School of MedicineClass of 2016
Certifications & Licensure
GA State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze
Cancer. 2024-06-15 - 4 citationsRepeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay
JCO Precision Oncology. 2024-04-01 - 11 citationsBaseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.Tony Z Zhuang, Deepak Ravindranathan, Yuan Liu, Dylan J Martini, Jacqueline T Brown
The Oncologist. 2023-03-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
